Clinical Trial Update: A Phase I Study of PepGNP-ChikV in Healthy Volunteers [EARLY_Phase 1]

View source ↗

Summary

Phase I study of PepGNP-ChikV in healthy volunteers is not yet recruiting, evaluating a chikungunya-targeted intervention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chikungunya

Drugs mentioned

• PepGNP-ChikV

Snippet

Sponsor: Gylden Pharma Ltd | Conditions: Chikungunya, Chikungunya Fever | EARLY_Phase 1 | Status: NOT_YET_RECRUITING